HomeCompareCICOF vs MRK

CICOF vs MRK: Dividend Comparison 2026

CICOF yields 11.39% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CICOF wins by $1049205.20M in total portfolio value
10 years
CICOF
CICOF
● Live price
11.39%
Share price
$1.94
Annual div
$0.22
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1049205.25M
Annual income
$1,031,807,742,068.50
Full CICOF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — CICOF vs MRK

📍 CICOF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCICOFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CICOF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CICOF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CICOF
Annual income on $10K today (after 15% tax)
$968.43/yr
After 10yr DRIP, annual income (after tax)
$877,036,580,758.23/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, CICOF beats the other by $877,036,572,429.81/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CICOF + MRK for your $10,000?

CICOF: 50%MRK: 50%
100% MRK50/50100% CICOF
Portfolio after 10yr
$524602.65M
Annual income
$515,903,875,933.32/yr
Blended yield
98.34%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CICOF
Analyst Ratings
1
Buy
1
Hold
1
Sell
Consensus: Buy
Altman Z
1.6
Piotroski
7/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CICOF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCICOFMRK
Forward yield11.39%2.76%
Annual dividend / share$0.22$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$1049205.25M$56.8K
Annual income after 10y$1,031,807,742,068.50$9,798.13
Total dividends collected$1048032.70M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: CICOF vs MRK ($10,000, DRIP)

YearCICOF PortfolioCICOF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$12,979$2,278.66$11,206$366.19+$1.8KCICOF
2$19,415$5,527.84$12,650$502.35+$6.8KCICOF
3$36,230$15,456.44$14,407$694.19+$21.8KCICOF
4$92,680$53,912.87$16,585$967.82+$76.1KCICOF
5$356,946$257,779.31$19,342$1,363.89+$337.6KCICOF
6$2,237,657$1,855,724.73$22,913$1,947.19+$2.21MCICOF
7$24,138,841$21,744,547.86$27,662$2,823.89+$24.11MCICOF
8$464,277,913$438,449,352.83$34,159$4,173.35+$464.24MCICOF
9$16,259,355,660$15,762,578,293.54$43,337$6,308.80+$16259.31MCICOF
10$1,049,205,252,625$1,031,807,742,068.50$56,776$9,798.13+$1049205.20MCICOF

CICOF vs MRK: Complete Analysis 2026

CICOFStock

COSCO SHIPPING Holdings Co., Ltd., an investment holding company, engages in the container shipping, container terminals, and other terminal related businesses in the United States, Europe, the Asia Pacific, Mainland China, and internationally. The company operates through Container Shipping Business and Terminal Business segments. It offers freight forwarding and transportation, vessel chartering, marine, vessel management, manning, and liner agency. The company was formerly known as China COSCO Holdings Company Limited and changed its name to COSCO SHIPPING Holdings Co., Ltd. in November 2016. COSCO SHIPPING Holdings Co., Ltd. was incorporated in 2005 and is based in Shanghai, the People's Republic of China.

Full CICOF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this CICOF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CICOF vs SCHDCICOF vs JEPICICOF vs OCICOF vs KOCICOF vs MAINCICOF vs JNJCICOF vs ABBVCICOF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.